Related Experiment Video

Updated: Apr 24, 2026

Infecting Mice with Malassezia spp. to Study the Fungus-Host Interaction
06:19

Infecting Mice with Malassezia spp. to Study the Fungus-Host Interaction

Published on: November 6, 2019

16.5K

Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient

Annabelle de St Maurice1, Haydar Frangoul, Alice Coogan

  • 1Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Pediatric Transplantation
|September 5, 2014
PubMed

Insights

Malassezia restricta can cause invasive splenic infections in immunocompromised patients. Molecular diagnostics are crucial for timely treatment of these challenging fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pediatric Oncology

Background:

  • Malassezia species are common skin commensals.
  • They can cause invasive infections in vulnerable populations like premature infants and immunocompromised hosts.
  • Diagnosing Malassezia infections is difficult due to their fastidious growth requirements.

Observation:

  • A case of a pediatric oncology patient is presented.
  • The patient developed splenic lesions.
  • These lesions were found to be secondary to Malassezia restricta.

Findings:

  • Malassezia restricta was identified as the causative agent of splenic lesions.
  • This highlights the potential for Malassezia to cause deep-seated infections in immunocompromised individuals.
  • Molecular techniques can assist in the diagnosis of such infections.

Implications:

  • This case underscores the importance of considering fungal infections in immunocompromised patients with unexplained lesions.
  • Molecular diagnostic methods are valuable for accurate and rapid identification of Malassezia species.
  • Early diagnosis and targeted treatment are essential for improving outcomes in invasive Malassezia infections.
Keywords:
hepatosplenic candidiasisimmunodeficiencymalassezia

More Related Videos

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

2.5K

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
775
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
918
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
129